Khwanchai Nantayo

Digitalization is redefining healthcare and how we support patients.   Docquity is therefore transforming Patient Support Programs (PSPs) into digital-first experiences that deliver timely, personalized care at scale. Through DocquityCare, we help pharma partners reach more patients through data-driven, omnichannel solutions. In Thailand, for example, we recently collaborated with a leading pharma to educate tens of thousands of patients and caregivers on cancer care and boost respiratory syncytial virus (RSV) vaccine awareness during a seasonal spike, effectively registering eligible patients into adherence programs. Christophe Meugnier, Docquity CCO and GM of Vietnam & Thailand, shares how digitalizing patient engagement closes the gap between medical innovation and real-world care.    💡 Learn more in the BioPharma APAC interview link in comments.    #PatientSupport #DocquityCare #CancerCare #RSVVaccine 

29

1 ความคิดเห็น

Rare diseases shouldn't mean rare support. As part of our ongoing commitment to underserved patient communities, DKSH Business Unit Healthcare continues to support efforts to expand access to treatment and medical innovation for rare diseases, including XLH. Together with the Thai Society for Pediatric Endocrinology, the Thai Rare Disease Foundation, and the XLH Community, DKSH Thailand is raising awareness of X-linked hypophosphatemia (XLH), a rare genetic bone disorder caused by low phosphate levels that can lead to skeletal deformities, impaired growth, and chronic pain. This initiative highlights the importance of early diagnosis and timely treatment, while also encouraging greater social understanding and empathy. It aims to build a community where every rare disease patient feels seen, supported, and empowered. Read more: https://bit.ly/4rtzvDM #DKSHHealthcare #HealthcareForAll #DKSHThailand #RareDisease #XLH

23

Market Size: Tk 36,963 Cr (+12.4% YoY Grwth) Q2 2025:Tk 9,384 Cr (+3.7% YoY Grwth) Top 3 players = 40% of Market share Top 5 -53% & Top 10-75% Market share Key leaders are Square (17.4%), Incepta (12.8%), Beximco (9.6%), Healthcare Pharma (7.7%), and Renata (5.8%). The Big 3 Square, Incepta, and Beximco are growing in line with the market growth of 12%. Renata, Eskayef, Opsonin, Popular, ACME, A.C.I., and Radiant are outpacing overall market growth, capturing share from MNCs and small local players.

80

2 ความคิดเห็น

Zuellig Pharma’s 2024 Sustainability Report is now live. It showcases our latest progress in advancing health, equity, and environmental responsibility across Asia.   Our journey to make healthcare more accessible in Asia continues to be guided by our commitment to the highest standards of quality and excellence across our operations, from distributing life-saving medicines responsibly to fostering a diverse and inclusive workplace.   This year, we set a new benchmark for the road transport sector with a fourth consecutive EcoVadis Platinum Medal, and an “A” rating from CDP for Climate Change disclosure.   Transparent reporting continues to be a priority for us, and we aligned our disclosures with the Global Reporting Initiative (GRI). Our report has also been externally verified, validating our commitment to rigorous, globally aligned sustainability governance.   We are excited about the progress and together with our partners, remain committed to building a healthier and more sustainable future.   Check out the highlights below or download the full 2024 Sustainability Report to explore how we’re building a healthier, more sustainable future: https://lnkd.in/gEaQ4gAZ   #ZuelligPharma #MakingHealthcareMoreAccessible #Sustainability #ESG 

128

🧠💊 Want to grow as a leader in pharmacy? Start by growing through real experiences. Whether you're behind the counter or managing daily operations, every challenge you face is a chance to level up. This Six-Stage Professional Growth Model from Vietnam shows how real learning happens — not just in classrooms, but on the job, every single day. Here's how you can apply it in your retail pharmacy career: 1️⃣ Face New Challenges – From tough customer questions to inventory issues, treat each problem as a learning opportunity. 2️⃣ Reflect on What Happened – Ask: What went well? What could I do better next time? 3️⃣ Spot the Patterns – Notice recurring issues or solutions. Build on what you've learned. 4️⃣ Try Something New – Adjust your approach and see how it works. Small experiments = big growth. 5️⃣ Build Your Thinking Toolbox – Over time, you'll develop decision-making habits that make you faster and more confident. 6️⃣ Grow Your Capabilities – With experience, you'll show real leadership—through wisdom, responsibility, and trust. 📈 Each stage builds on the last. The more cycles you go through, the more confident and capable you become — not just as a pharmacist, but as a leader. 💡 Leadership isn't about your title — it's about how you learn, think, and respond to the world around you. Real growth comes from doing, reflecting, and improving. Not from waiting for the perfect training course or promotion. The pharmacy professionals who stand out aren't always the ones with the most certifications. They're the ones who turn everyday moments into learning moments. They ask better questions. They stay curious. They take ownership of their development. 👉 To all my fellow pharmacy professionals: What's one challenge you faced recently that helped you grow? Drop it in the comments. Let's learn from each other. #PharmacyCareer #RetailPharmacy #LeadershipDevelopment #LifelongLearning #OnTheJobGrowth #PharmacyProfessionals #YoungPharmacists #VietnamPharmacy #RealWorldLearning

21

1 ความคิดเห็น

🌱 Turning Pizza into Purpose: The Pizza 4P’s Story 🍕 I was really inspired in Vietnam and Cambodia about the concept, the no waste concept and the subastanbility report, see the report attached as pdf. When Masuko Yosuke and Sanae Takasugi opened the first Pizza 4P's in Ho Chi Minh City, they weren’t just building a restaurant — they were planting the seeds of a movement. Their vision? Delivering wow, sharing happiness — not just through incredible pizza, but by creating a business that gives more than it takes. ✨ From homemade cheese to farm-to-table ingredients, every slice tells a story of care, collaboration, and community. But what truly sets Pizza 4P's apart is its deep-rooted commitment to sustainability. 🔁 Zero Waste Philosophy Pizza 4P's embraces a circular economy, aiming for a future with zero waste. Whether it’s turning used cooking oil into soap, composting food waste, or upcycling furniture from old wood, the team is showing how a restaurant can serve both people and the planet. 📊 Sustainability Report Their recent Sustainability Report is more than just numbers — it’s a transparent journey of challenges, creativity, and continuous improvement. With clear KPIs on CO₂ emissions, waste reduction, employee well-being, and local sourcing, it’s a benchmark for what socially responsible F&B can look like. 💼 Company Profile On LinkedIn, Pizza 4P’s shares more than job posts. They share a mission — to inspire love and responsibility in business. Their culture blends Japanese precision, Vietnamese warmth, and global thinking, creating a brand that grows through purpose, not just profit. 👉 Whether you're a sustainability advocate, entrepreneur, or food lover — Pizza 4P’s is a brand to watch, learn from, and cheer for. 🌍 This is not just about pizza. This is about the future of food. And it’s delicious. #Sustainability #ZeroWaste #Leadership #PurposeDriven #FoodInnovation #Pizza4Ps #CircularEconomy #ImpactBusiness #SustainableHospitality

10

How is DKSH Technology shaping the future of genomic innovation in Asia?   Genetic sequencing, a technique used to determine the exact sequence of bases in a genome, is very crucial to multiple industries and a growing opportunity in the laboratory services sector.    In Vietnam, our customer KTest, a pioneer in genomic services, recently made a strategic leap by investing in PacBio's Onso system. This advanced benchtop short-read DNA sequencer utilizes PacBio’s ultra-accurate Sequencing by Binding (SBB) technology.   With DKSH Technology providing expertise and support, this strategic investment strengthens KTest’s competitive edge, enhances laboratory capabilities, and improves operational efficiency.  📖 Read more here: https://bit.ly/3RyF974 #DKSHTechnology #PacBio #KTest #LifeScience #GeneSequencing #SuccessStory

22

Pharma communication in APAC is rarely linear. HCPs engage across multiple digital and offline channels, each with its own expectations. When global content is applied without adaptation, clarity and relevance can be affected. In our latest insight, we examine how content localization helps pharma messages align better with APAC’s diverse communication landscape. Read here: https://lnkd.in/g_DAnhNn #APAC #PharmaMarketing #LifeSciences #HCP

16

North Korea – Generic Pharmaceutical Retail Market (2025)   1. Market Size & Growth No official data on market size or growth. Nearly 100% of pharmaceuticals are generics, mostly domestically produced or donated.   2. Market Structure No private retail pharmacies; all distribution is state-run. Centralized under the Ministry of Public Health.   3. eCommerce Segment Non-existent. No ePharmacy or digital prescription infrastructure. 4. OTC Segment Limited OTC availability via state dispensaries. Herbal and traditional medicines widely used.   5. Market Dynamics Access through state health system only. Aid agencies (WHO, UNICEF) supply essential generics. Public receives medicines via rationed or subsidized channels.   6. Consumer Behaviour No private purchasing norms. Consumers rely on state clinics or traditional remedies.   7. Key Drivers Humanitarian supply chains, basic local production Heavy reliance on essential medicines list   8. Key Challenges International sanctions, outdated infrastructure, no import channels Severe drug shortages, poor regulatory transparency   9. Opportunities None for private sector. Only NGO or UN-based humanitarian access routes possible.   10. Regulatory Environment Controlled by Ministry of Public Health No published framework for medicine approval or retail operations  

24

3 ความคิดเห็น

BJC Healthcare Forms Strategic Joint Venture with BLC to Drive Sustainable Growth in Thailand’s Pharmaceutical and Healthcare Industry, Enhancing Access to Quality Health Products Across Southeast Asia Berli Jucker Public Company Limited (BJC), through its subsidiary BJC Healthcare Co., Ltd., led by Mrs. Thapanee Techajareonvikul, Chief Executive Officer and President of BJC, together with Miss Panisara Chairungrat, RPh, First Executive Vice President of BJC Healthcare, has entered into a strategic joint venture with Bangkok Lab & Cosmetic Public Company Limited (BLC), represented by Mr. Suwit Ngampoopan, RPh, Chief Executive Officer, and Mr. Somchai Pisopahutharn, RPh, Chief Financial Officer. The signing ceremony marked the formation of a joint venture company that will focus on the development of pharmaceutical innovations and healthcare products under the BJC Healthcare brand. This collaboration aims to elevate the quality of life for patients and the general public by promoting sustainable and accessible healthcare solutions. The joint venture aspires to become a regional leader in the pharmaceutical and healthcare sector in Asia, with the first wave of BJC Healthcare-branded products expected to be ready by Q4 of 2025. The ceremony took place at the BJC House Headquarters on May 16, 2025, with senior executives from both organizations in attendance. This partnership represents a pivotal step in advancing BJC’s vision to become a leading distributor of world-class healthcare products and medical devices. It also significantly strengthens the company’s product portfolio under the BJC Healthcare brand. Currently, BJC Healthcare operates in the distribution of pharmaceuticals, beauty products, and medical equipment from globally recognized brands. The company emphasizes innovation to meet the evolving needs of patients and consumers, while enhancing its market expansion across the Asia-Pacific region.   Through this collaboration, BJC and BLC aim to drive long-term, sustainable growth and lay the foundation for future health-tech development across Southeast Asia.

42